Abstract
Hereditary gingival fibromatosis (HGF) is the most common genetic form of gingival fibromatosis which is featured as a localized or generalized overgrowth of gingivae. HGF is genetically heterogeneous and usually be transmitted as an autosomal-dominant inheritance pattern, also can be as autosomal-recessive or occur sporadically. Currently only two genes (SOS1 and REST), as well as four loci (2p22.1, 2p23.3-p22.3, 5q13-q22, and 11p15), have been identified as associated with HGF in a dominant inheritance pattern. Here we report thirteen individuals with autosomal-dominant non-syndromic HGF from a large four-generation Chinese family. Whole-exome sequencing followed by further genetic co-segregation analysis was performed for the family members across three generations. A novel heterozygous missense mutation (NM_001099220.3: c.2812G>A) in zinc finger protein 862 gene (ZNF862) was identified, and it is absent among the population as reported from the Genome Aggregation Database, Exome Aggregation Consortium (ExAC) and 1000 Genomes. ZNF862 is a predicted intracellular protein which function is not yet identified, as a zinc finger protein it may be involved in transcriptional regulation. ZNF862 is expressed ubiquitously across tissues, it may play various roles under different physiological condition. Here for the first time we identify the physiological role of ZNF862 for the association with the HGF trait.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We thank the support by the funding from National Natural Science Foundation of China (51772144); the Medical Science and Technology Development Foundation, Nanjing Department of Health (YKK18121); Major Project in 13th Five-year of Medical Science and Technology Innovation Platform, Nanjing Department of Health (ZDX16007); Jiangsu Province Natural Science Foundation of China (BK20170143).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data Availability The sequencing data supporting this study have been deposited in the China Genebank Nucleotide Sequence Archive (https://db.cngb.org/cnsa, accession number CNP0000995).
